These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8922875

  • 21. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S, Au CL, Hadisaputra W, Affandi B, Rogers PA.
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 23. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF.
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [Abstract] [Full Text] [Related]

  • 24. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
    Di X, Li Y, Zhang C, Jiang J, Gu S.
    Contraception; 1999 Sep; 60(3):161-6. PubMed ID: 10640160
    [Abstract] [Full Text] [Related]

  • 25. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A, Leong WP, Ratnam SS, Viegas OA.
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [Abstract] [Full Text] [Related]

  • 26. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB, Lobo RA.
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [Abstract] [Full Text] [Related]

  • 27. A five-year evaluation of NORPLANT II implants in China.
    Gu S, Du M, Zhang L, Liu Y, Wang S, Sivin I.
    Contraception; 1994 Jul; 50(1):27-34. PubMed ID: 7924320
    [Abstract] [Full Text] [Related]

  • 28. Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: haemostatic changes.
    Singh K, Viegas OA, Koh S, Singh P, Ratnam SS.
    Contraception; 1989 Feb; 39(2):155-64. PubMed ID: 2495890
    [Abstract] [Full Text] [Related]

  • 29. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
    Akhter H, Dunson TR, Amatya RN, Begum K, Chowdhury T, Dighe N, Krueger SL, Rahman S.
    Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
    [Abstract] [Full Text] [Related]

  • 30. A longitudinal study of changes in endometrial microvascular density in Norplant implant users.
    Hickey M, Simbar M, Young L, Markham R, Russell P, Fraser IS.
    Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627
    [Abstract] [Full Text] [Related]

  • 31. Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
    Contraception; 1993 Aug; 48(2):120-32. PubMed ID: 8403909
    [Abstract] [Full Text] [Related]

  • 32. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE, Odlind V, Johansson ED, Nordström ML.
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [Abstract] [Full Text] [Related]

  • 33. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR, Lacarra M, McCarthy T, Holma P.
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [Abstract] [Full Text] [Related]

  • 34. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
    Affandi B, Cekan SZ, Boonkasemsanti W, Samil RS, Diczfalusy E.
    Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
    Toppozada MK, Ramadan M, el-Sawi M, Mehanna MT, Khamis Y, Marzouk S.
    Contraception; 1997 Jan; 55(1):7-10. PubMed ID: 9013054
    [Abstract] [Full Text] [Related]

  • 38. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM, Rogers PA, Affandi B.
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [Abstract] [Full Text] [Related]

  • 39. Norplant subdermal contraceptive system: experience in Taiwan.
    Tseng LH, Lee TY, Yang YS, Ko TM, Chuang SM.
    Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.